Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ABX196 |
| Trade Name | |
| Synonyms | ABX-196|ABX 196 |
| Drug Descriptions |
ABX196 is a synthetic analog of alpha-galactosylceramide that potentially induces activation of invariant natural killer T cells and enhances anti-tumor immune response (PMID: 36198025). |
| DrugClasses | |
| CAS Registry Number | 1161877-58-2 |
| NCIT ID | C172187 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ABX196 | ABX196 | 0 | 0 |
| ABX196 + Nivolumab | ABX196 Nivolumab | 0 | 1 |
| ABX196 + Sorafenib | ABX196 Sorafenib | 0 | 0 |
| ABX196 + unspecified PD-1 antibody | ABX196 unspecified PD-1 antibody | 0 | 0 |